Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing research has found.

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.